Cell Based Bioassays
When: June 4, 2019 11:00am CST
Cell- based bioassays are critical to determining the potency of biopharmaceuticals. The ICHQ6 B defines potency as “The measure of the biological activity using a quantitative biological assay based on the attribute of the product which is linked to the relevant biological properties.” Potency directly reflects the subtleties of the tertiary and quaternary structure of a biopharmaceutical in a manner in which physicochemical methods are incapable. But cell bioassays are also challenging as they involve use of living systems and their inherent variability. This webinar will discuss the
- Types of Bioassays
- Laboratory design
About the Speaker: Glenn Petri, PhD
Dr. Glenn Petrie is a Senior Scientific Advisor at Eurofins. He has over 20 years experience in the drug development arena with a focus on biopharmaceuticals. As a director at a major CRO he has served as team leader in the development, CMC design and IND submissions for a wide variety of biopharmaceuticals (monoclonal antibodies, antibody drug conjugates, fusion proteins, etc.). Dr. Petrie is a subject matter expert in the analysis of proteins including UPLC, mass spectroscopy, ELISAs and capillary electrophoresis. He received his B.A. in Biochemistry at Rice University and his doctorate in Biochemistry at the University of Illinois Urbana-Champaign.